loadpatents
name:-0.019633054733276
name:-0.0042331218719482
name:-0.0060849189758301
REIDENBERG; BRUCE Patent Filings

REIDENBERG; BRUCE

Patent Applications and Registrations

Patent applications and USPTO patent grants for REIDENBERG; BRUCE.The latest application filed is for "delta opioid agonist, mu opioid antagonist compositions and methods for treating parkinsons disease".

Company Profile
7.6.18
  • REIDENBERG; BRUCE - RYE NY
  • Reidenberg; Bruce - Bedminster NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Delta Opioid Agonist, Mu Opioid Antagonist Compositions And Methods For Treating Parkinsons Disease
App 20210220349 - VERSI; EBRAHIM ;   et al.
2021-07-22
Delta opioid agonist mu opioid antagonist compositions and methods for treating Parkinsons disease
Grant 10,973,815 - Versi , et al. April 13, 2
2021-04-13
Skin-penetrating Formulation Of Taurolidine
App 20210093641 - Reidenberg; Bruce ;   et al.
2021-04-01
Taurolidine Treatment For Myc-expressing Tumors In Mammalian Bodies
App 20190381060 - Reidenberg; Bruce ;   et al.
2019-12-19
Methods And Compositions For Treating Neuroblastoma In A Juvenile Mammalian Body
App 20190381058 - Reidenberg; Bruce ;   et al.
2019-12-19
Neuroblastoma Treatment With Taurolidine Hydrolysis Products
App 20190381059 - Reidenberg; Bruce ;   et al.
2019-12-19
Field sterilizer and vascular connector kit
Grant 10,478,640 - Reidenberg , et al. Nov
2019-11-19
Methods And Pharmaceutical Compositions For Treating Candida Auris In Blood
App 20190192529 - DiLuccio; Robert ;   et al.
2019-06-27
Delta Opioid Agonist Mu Opioid Antagonist Compositions And Methods For Treating Parkinsons Disease
App 20190038620 - VERSI; EBRAHIM ;   et al.
2019-02-07
Skin-penetrating Formulation Of Taurolidine
App 20180117058 - Reidenberg; Bruce ;   et al.
2018-05-03
Field Sterilizer And Vascular Connector Kit
App 20170274223 - Reidenberg; Bruce ;   et al.
2017-09-28
Abuse Resistant Opioid Transdermal Delivery Device Containing Opioid Antagonist Microspheres
App 20170157114 - Reidenberg; Bruce ;   et al.
2017-06-08
Skin-penetrating Formulation Of Taurolidine
App 20170100407 - Reidenberg; Bruce ;   et al.
2017-04-13
Compositions For The Treatment Of Joints
App 20170056561 - DiLuccio; Robert ;   et al.
2017-03-02
Tamper resistant transdermal dosage form
Grant 8,790,689 - Howard , et al. July 29, 2
2014-07-29
Tamper resistant transdermal dosage form
Grant 8,778,382 - Howard , et al. July 15, 2
2014-07-15
Abuse Resistant Opioid Transdermal Delivery Device Containing Opioid Antagonist Microspheres
App 20080233178 - Reidenberg; Bruce ;   et al.
2008-09-25
Transdermal Dosage Form Comprising An Active Agent And A Salt And A Free-base Form Of An Adverse Agent
App 20080020028 - Shevchuk; Ihor ;   et al.
2008-01-24
Tamper resistant transdermal dosage form
App 20060198881 - Howard; Stephen A. ;   et al.
2006-09-07
Tamper resistant transdermal dosage form
App 20050002997 - Howard, Stephen A. ;   et al.
2005-01-06
Transdermal dosage form comprising an active agent and a salt and free-base form of an adverse agent
App 20040126323 - Shevchuk, Ihor ;   et al.
2004-07-01
Acyl opioid antagonists
App 20040033253 - Shevchuk, Ihor ;   et al.
2004-02-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed